EligibleTrials

Reducing Breathlessness With Dronabinol in COPD Patients

Recruiting · NCT06473701 · Interventional (participants receive a specific treatment) · Lead sponsor: Vejle Hospital

View the official record on ClinicalTrials.gov →
COPD

Interventions studied

Dronabinol 2.5mg CapsulePlacebo

What this trial is about

This clinical trial examines whether Dronabinol, which contains the synthetic psychoactive compound tetrahydrocannabinol (THC), can alleviate severe breathlessness in patients with severe and very severe chronic obstructive pulmonary disease (COPD).

Who can take part

Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Phase 3
Study type
Interventional (participants receive a specific treatment)

Inclusion criteria

Exclusion criteria

Where it is running

1 location listed.

Read the full protocol, contacts and eligibility on ClinicalTrials.gov →

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.